Trastuzumab emtansine Archives - Medical Conferences

Tucatinib improves PFS in metastatic, HER2-positive breast cancer

Presented By

Prof. Sara Hurvitz, Fred Hutchinson Cancer Center, WA, USA

Trial

Phase 3, HER2CLIMB-02

Conference

SABCS 2023

Type

News article

11 January 2024 15:01

OS benefit of adjuvant T-DM1 in early breast cancer with residual disease after neoadjuvant therapy

Presented By

Prof. Sibylle Loibl, Goethe University, Germany

Trial

Phase 3, KATHERINE

Conference

SABCS 2023

Type

News article

11 January 2024 15:01

Trastuzumab deruxtecan outperforms trastuzumab emtansine

Presented By

Dr Sara Hurvitz, University of California, CA, USA

Trial

Phase 3, DESTINY-Breast03

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 18:02

SABCS 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

SABCS 2021

10 January 2022 20:59

Trastuzumab deruxtecan triples PFS

Presented By

Dr Javier Cortés, International Breast Cancer Center Barcelona, Spain

Trial

Phase 3, DESTINY-Breast03

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:51

Ado-trastuzumab emtansine a potential new treatment option for HER2-amplified advanced salivary gland cancer

Presented By

Dr Bob T. Li, Memorial Sloan Kettering Cancer Centre, USA

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 23:13